Gestational diabetes & diabetes in pregnancy

Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study

Lancet Diabetes EndocrinolPublished Prespecified extension study of the AiDAPT randomised controlled trial

Primary result · TIRResult — go to the resultAdjusted treatment difference 15 % 95% CI 7–22

Authors' conclusion

Participants in the HCL group maintained 70% TIR during the first 6 months postpartum, supporting continued use of HCL rather than standard insulin therapy for people with diabetes once they have given birth.

Study context

Population
Women with T1D followed up for 6 months postpartum after the AiDAPT pregnancy trial, nine UK sites; mean age 31 years, early pregnancy HbA1c 59.4 mmol/molof 124 AiDAPT participants
Participants
57 women
Comparison
Hybrid closed loop (HCL) vs standard insulin therapy with CGM
Primary endpoint
Between-group difference in % TIR (3.9-10.0 mmol/L), months 0 up to 3, months 3 to 6, and over 6 months postpartum
Follow-up
6 months postpartum
Methodological detailsmulticentre, stratified by clinical site
  • Multicentre
  • Stratified by clinical site

Primary result

TIR

Adjusted treatment difference

15 %

95% CI 7–22

By group

HCLvs Standard care
adjusted treatment difference 15 % (95% CI 7–22)

As reported in the abstract

Further findings

OutcomeDifference (%) (95% CI)
Hyperglycaemia (>10.0 mmol/L) · 6 months postpartum−14 (−23% to −6%)
OutcomeDifference (mmol/L) (CI)
Mean CGM glucose · 6 months postpartum−1.3 (−2.3 to −0.3)

Treatment effect by postpartum period · 0 up to 3 months vs 3 to 6 months

No treatment effect changes depending on postpartum period

Safety

Hypoglycaemia · 6 months postpartum

Hypoglycaemia rates were low, with no between-group differences
2.4% vs 2.6%
No unanticipated safety problems

Original publication

Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study. Lancet Diabetes Endocrinol. Published 27 January 2025. doi:10.1016/s2213-8587(24)00340-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.